These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36525559)

  • 1. Prodrug Nanosensitizer Overcomes the Radiation Resistance of Hypoxic Tumor.
    Qian L; Li Q; Ding Z; Luo K; Su J; Chen J; Zhu G; Gan Z; Yu Q
    ACS Appl Mater Interfaces; 2022 Dec; 14(51):56454-56470. PubMed ID: 36525559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Hypoxic Radiosensitizer-Prodrug Liposome Delivery DNA Repair Inhibitor Dbait Combination with Radiotherapy for Glioma Therapy.
    Liu H; Cai Y; Zhang Y; Xie Y; Qiu H; Hua L; Liu X; Li Y; Lu J; Zhang L; Yu R
    Adv Healthc Mater; 2017 Jun; 6(12):. PubMed ID: 28371526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PROTAC Prodrug-Integrated Nanosensitizer for Potentiating Radiation Therapy of Cancer.
    Zhang S; Lai Y; Pan J; Saeed M; Li S; Zhou H; Jiang X; Gao J; Zhu Y; Yu H; Zhang W; Xu Z
    Adv Mater; 2024 Jun; 36(23):e2314132. PubMed ID: 38353332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming Radioresistance in Tumor Therapy by Alleviating Hypoxia and Using the HIF-1 Inhibitor.
    Zhou X; Liu H; Zheng Y; Han Y; Wang T; Zhang H; Sun Q; Li Z
    ACS Appl Mater Interfaces; 2020 Jan; 12(4):4231-4240. PubMed ID: 31912727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep-Penetrating Triple-Responsive Prodrug Nanosensitizer Actuates Efficient Chemoradiotherapy in Pancreatic Ductal Adenocarcinoma Models.
    Tang X; Du X; Yu Y; Qin M; Qian L; Zhang M; Yang Y; Yu Q; Gan Z
    Small; 2022 Aug; 18(31):e2202834. PubMed ID: 35808966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-targeting platinum(IV) amphiphilic prodrug nano-assembly as radiosensitizer for synergistic and safe chemoradiotherapy of hepatocellular carcinoma.
    Xiao X; Wang Y; Chen J; Qin P; Chen P; Zhou D; Pan Y
    Biomaterials; 2022 Oct; 289():121793. PubMed ID: 36126545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical radiosensitizers for use in radiotherapy.
    Wardman P
    Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):397-417. PubMed ID: 17478086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nano-enabled coordination platform of bismuth nitrate and cisplatin prodrug potentiates cancer chemoradiotherapy
    Ma YC; Tang XF; Xu YC; Jiang W; Xin YJ; Zhao W; He X; Lu LG; Zhan MX
    Biomater Sci; 2021 May; 9(9):3401-3409. PubMed ID: 33949448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of mitochondrial ROS accumulation and radiotherapeutic efficacy using a Gd-doped titania nanosensitizer.
    Chen Y; Li N; Wang J; Zhang X; Pan W; Yu L; Tang B
    Theranostics; 2019; 9(1):167-178. PubMed ID: 30662560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxic radiosensitizers and hypoxic cytotoxins in radiation oncology.
    Weinmann M; Welz S; Bamberg M
    Curr Med Chem Anticancer Agents; 2003 Sep; 3(5):364-74. PubMed ID: 12871083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-responsive block copolymer radiosensitizers as anticancer drug nanocarriers for enhanced chemoradiotherapy of bulky solid tumors.
    Yin W; Qiang M; Ke W; Han Y; Mukerabigwi JF; Ge Z
    Biomaterials; 2018 Oct; 181():360-371. PubMed ID: 30098571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural compound gambogic acid radiosensitizes nasopharyngeal carcinoma cells under hypoxic conditions.
    Yang M; Yang Y; Cui H; Guan Z; Yang Y; Zhang H; Chen X; Zhu H; Yang X; Cai J; Cheng H; Sun X
    Tumori; 2016; 102(2):135-43. PubMed ID: 26357974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-selective radiosensitisation by SN38023, a bioreductive prodrug of DNA-dependent protein kinase inhibitor IC87361.
    Wong WW; Jackson RK; Liew LP; Dickson BD; Cheng GJ; Lipert B; Gu Y; Hunter FW; Wilson WR; Hay MP
    Biochem Pharmacol; 2019 Nov; 169():113641. PubMed ID: 31541630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering biomimetic nanosystem targeting multiple tumor radioresistance hallmarks for enhanced radiotherapy.
    Wang S; Cao H; Zhao CC; Wang Q; Wang D; Liu J; Yang L; Liu J
    Sci China Life Sci; 2024 Jul; 67(7):1398-1412. PubMed ID: 38602587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a hypoxia-triggered and hypoxic radiosensitized liposome as a doxorubicin carrier to promote synergetic chemo-/radio-therapy for glioma.
    Liu H; Xie Y; Zhang Y; Cai Y; Li B; Mao H; Liu Y; Lu J; Zhang L; Yu R
    Biomaterials; 2017 Mar; 121():130-143. PubMed ID: 28088075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenic Radiation Therapy for Enhanced Antitumor Immunity via a Core-Shell Nanosensitizer-Mediated Immunosuppressive Tumor Microenvironment Modulation.
    Huang N; Tang XY; Meng W; Lai YH; Zhou X; Yu XZ; Zhang WH; Chen JX
    ACS Nano; 2023 Oct; 17(20):19853-19864. PubMed ID: 37812400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting and Treatment of Tumor Hypoxia by Newly Designed Prodrug Possessing High Permeability in Solid Tumors.
    Ikeda Y; Hisano H; Nishikawa Y; Nagasaki Y
    Mol Pharm; 2016 Jul; 13(7):2283-9. PubMed ID: 27187083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitroimidazoles as anti-tumor agents.
    Liu K; Zhu HL
    Anticancer Agents Med Chem; 2011 Sep; 11(7):687-91. PubMed ID: 21521156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperthermia-triggered release of hypoxic cell radiosensitizers from temperature-sensitive liposomes improves radiotherapy efficacy in vitro.
    Sadeghi N; Kok RJ; Bos C; Zandvliet M; Geerts WJC; Storm G; Moonen CTW; Lammers T; Deckers R
    Nanotechnology; 2019 Jun; 30(26):264001. PubMed ID: 30836341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional Upgrading of an Organo-Ir(III) Complex to an Organo-Ir(III) Prodrug as a DNA Damage-Responsive Autophagic Inducer for Hypoxic Lung Cancer Therapy.
    Wang MM; Deng DP; Zhou AM; Su Y; Yu ZH; Liu HK; Su Z
    Inorg Chem; 2024 Mar; 63(10):4758-4769. PubMed ID: 38408314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.